Industry News - Tag: Recordati

You can read our Premium News Service in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.

Recordati sets out three-year growth plan
Premium

7 May 2021

Recordati plans to increase sales of its Procto-Glyvenol haemorrhoid treatment by more than a third by 2023 as part of a three-year plan which also includes developing new probiotic food supplements and acquisitions of OTC brands.

Read the full story